
Phreesia Inc (PHR) Stock Forecast & Price Target
Phreesia Inc (PHR) Analyst Ratings
Bulls say
Phreesia Inc is projected to achieve total revenue between $472.0 million and $482.0 million, reflecting a year-over-year growth of approximately 12% to 15%, surpassing prior consensus estimates. Notably, Network Solutions revenue is anticipated to grow by 25% year-over-year, outperforming market expectations, and contributing positively to overall financial performance. Additionally, the company's adjusted EBITDA guidance midpoint has increased by $2.0 million for FY26, indicating a strong bottom-line outlook that complements the healthy revenue projections.
Bears say
Phreesia Inc.'s financial outlook is negatively influenced by several key factors, including a projected slight decline in payment processing revenues due to seasonal effects, which signifies potential vulnerabilities in patient volume and spending patterns. The company's non-GAAP gross margin fell below expectations at 68.7%, reflecting challenges in maintaining profitability during a time of rising competitive pressures and economic uncertainties affecting healthcare spending. Additionally, the anticipated slowdown in organic growth and the broader economic downturn present substantial downside risks for future performance, potentially impacting the adoption of Phreesia's solutions across providers, payers, and life sciences.
This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.
Phreesia Inc (PHR) Analyst Forecast & Price Prediction
Start investing in Phreesia Inc (PHR)
Order type
Buy in
Order amount
Est. shares
0 shares